{"items": "50", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Amgen scraps experimental weight loss pill, moves forward with injection", "url": "https://www.cnbc.com/2024/05/02/amgen-scraps-experimental-weight-loss-pill-moves-forward-with-injection.html", "time_published": "20240502T210021", "authors": ["Annika Kim Constantino"], "summary": "Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107243224-1684411224877-gettyimages-1491059980-mt_15744_opmy4ayv.jpeg?v=1714684125&w=1920&h=1080", "source": "CNBC", "category_within_source": "Earnings", "source_domain": "www.cnbc.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.999919"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.031363, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.047465", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.047465", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.094762", "ticker_sentiment_score": "-0.199833", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BAC", "relevance_score": "0.047465", "ticker_sentiment_score": "0.039043", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.047465", "ticker_sentiment_score": "0.070909", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.066085", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For' - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38595739/pfizer-prospects-garner-mixed-sentiment-from-analysts-finally-the-pivot-investors-h", "time_published": "20240502T191539", "authors": ["Vandana Singh"], "summary": "Pfizer Inc PFE reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That's down 33% year-over-year, beating the consensus of 54 cents. The New York-based company witnessed a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}, {"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.275223, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.100729", "ticker_sentiment_score": "0.178448", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.199859", "ticker_sentiment_score": "0.301957", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.387374", "ticker_sentiment_score": "0.297737", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration - Merck & Co  ( NYSE:MRK ) ", "url": "https://www.benzinga.com/24/05/38592061/merck-reports-progress-on-the-cancer-front-as-it-prepares-for-keytruda-patent-expiration", "time_published": "20240502T165354", "authors": ["Upwallstreet"], "summary": "After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc MRK just reported encouraging data from its Phase III gastric cancer treatment trial after ending 2023 with good news from its combined treatment with Moderna Inc MRNA in fighting melanoma.", "banner_image": "https://cdn.benzinga.com/files/covid-still-life-with-vaccine_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.990893"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.135801, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.388018", "ticker_sentiment_score": "0.038939", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.057767", "ticker_sentiment_score": "-0.05802", "ticker_sentiment_label": "Neutral"}]}, {"title": "Genmab Announces Financial Results for the First Quarter of 2024", "url": "https://www.globenewswire.com/news-release/2024/05/02/2874427/0/en/Genmab-Announces-Financial-Results-for-the-First-Quarter-of-2024.html", "time_published": "20240502T150100", "authors": ["Genmab A/S"], "summary": "May 2, 2024 Copenhagen, Denmark. Interim Report for the First Quarter Ended March ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.796627"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.156708, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVS", "relevance_score": "0.030524", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.15173", "ticker_sentiment_score": "0.110284", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.407844", "ticker_sentiment_score": "0.175143", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.061003", "ticker_sentiment_score": "0.209114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.030524", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.", "url": "https://www.barrons.com/amp/articles/moderna-earnings-stock-price-17d46995", "time_published": "20240502T144700", "authors": ["Josh Nathan-Kazis"], "summary": "Moderna Scores an Earnings Beat. Next Up Is the RSV Shot. ...", "banner_image": "https://images.barrons.com/im-55059708/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.045239, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.348919", "ticker_sentiment_score": "-0.019663", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.060085", "ticker_sentiment_score": "-0.108001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Unusual Options Activity - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/insights/options/24/05/38584743/pfizer-unusual-options-activity", "time_published": "20240502T134648", "authors": ["Benzinga Insights"], "summary": "Investors with a lot of money to spend have taken a bearish stance on Pfizer PFE. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.069167, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.716023", "ticker_sentiment_score": "0.148579", "ticker_sentiment_label": "Neutral"}]}, {"title": "TIME Reveals the Inaugural TIME100 Health List of the World's Most Influential People in Health", "url": "https://www.benzinga.com/pressreleases/24/05/n38582784/time-reveals-the-inaugural-time100-health-list-of-the-worlds-most-influential-people-in-health", "time_published": "20240502T130000", "authors": ["PRNewswire"], "summary": "NEW YORK, May 2, 2024 /PRNewswire/ -- Today, TIME reveals the inaugural TIME100 Health list recognizing the 100 most influential individuals in health.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.24786, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.040011", "ticker_sentiment_score": "0.045291", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.040011", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.040011", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Novo Nordisk Dips As Q1 Wegovy Sales Double, But Miss Target", "url": "https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earning-q1-2024/", "time_published": "20240502T121800", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Novo Nordisk ( NVO ) stock eased a fraction early Thursday after the weight-loss drugs leader reported adjusted income of 81 cents per share on $9.36 billion in first-quarter sales. On average, analysts surveyed by FactSet expected Novo to earn 75 cents a share on $9.13 billion in sales.", "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/Stock-NovoNordisk-Denmark-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.272745, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.55533", "ticker_sentiment_score": "0.380214", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.151539", "ticker_sentiment_score": "0.632986", "ticker_sentiment_label": "Bullish"}]}, {"title": "ThetaRay Co-founder Mark Gazit Appointed Executive Chairman of the Global Management of N.E.W.S.\u00ae", "url": "https://www.newswire.ca/news-releases/thetaray-co-founder-mark-gazit-appointed-executive-chairman-of-the-global-management-of-n-e-w-s-r--838197114.html", "time_published": "20240502T110000", "authors": ["N.E.W.S"], "summary": "LAUSANNE, Switzerland , May 2, 2024 /CNW/ -- The N.E.W.S.\u00ae company, a global leader in leadership and organizational navigation, headquartered in Switzerland and operating in over 40 countries, today announced that Mark Gazit, co-founder and outgoing CEO of ThetaRay, has been appointed as its ...", "banner_image": "https://mma.prnewswire.com/media/2403536/Mark_Gazit.jpg?p=facebook", "source": "Canada Newswire", "category_within_source": "n/a", "source_domain": "www.newswire.ca", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.480822, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "META", "relevance_score": "0.076602", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOD", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DOX", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LRLCF", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BA", "relevance_score": "0.076602", "ticker_sentiment_score": "0.244717", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe - CytoSorbents  ( NASDAQ:CTSO ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38577409/cytosorbents-may-6-2024-virtual-kol-and-analyst-investor-day-star-t-pivotal-trial-topline-results-", "time_published": "20240502T110000", "authors": ["Globe Newswire"], "summary": "PRINCETON, N.J., May 02, 2024 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced that it will host ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.113939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.01965", "ticker_sentiment_score": "0.100602", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.01965", "ticker_sentiment_score": "0.059176", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.078482", "ticker_sentiment_score": "-0.003108", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.039289", "ticker_sentiment_score": "0.004982", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRI", "relevance_score": "0.01965", "ticker_sentiment_score": "0.054307", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.01965", "ticker_sentiment_score": "-0.027015", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.01965", "ticker_sentiment_score": "-0.027015", "ticker_sentiment_label": "Neutral"}]}, {"title": "Regeneron Falls On Earnings Miss", "url": "https://www.investors.com/news/technology/regeneron-stock-regeneron-pharmaceuticals-earnings-q1-2024/", "time_published": "20240502T104500", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "Regeneron Stock Falls As Biotech Giant's Earnings Miss Estimates Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/03/stock-regeneron-03-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.268774, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "REGN", "relevance_score": "0.401331", "ticker_sentiment_score": "0.315981", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.207571", "ticker_sentiment_score": "0.723851", "ticker_sentiment_label": "Bullish"}]}, {"title": "Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.", "url": "https://www.barrons.com/amp/articles/moderna-earnings-stock-price-17d46995", "time_published": "20240502T103000", "authors": ["Josh Nathan-Kazis"], "summary": "Moderna Scores a Beat. Next Up Is the RSV Shot. ...", "banner_image": "https://images.barrons.com/im-55059708/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.045239, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.348919", "ticker_sentiment_score": "-0.019663", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.060085", "ticker_sentiment_score": "-0.108001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?", "url": "https://www.investors.com/news/technology/moderna-stock-moderna-earnings-q1-2024/", "time_published": "20240502T103000", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Moderna Stock Is Nearing A Breakout, And Just Smashed First-Quarter Views Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/12/Stock-moderna-12-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.100762, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.675301", "ticker_sentiment_score": "0.217701", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.179788", "ticker_sentiment_score": "-0.036625", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer's Stock Is a Buy. Here Are Six Reasons Why.", "url": "https://www.fool.com/investing/2024/05/02/pfizers-stock-is-a-buy-here-are-six-reasons-why/", "time_published": "20240502T091500", "authors": ["George Budwell"], "summary": "The pharma-giant's shares could be poised for a trend reversal.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F775349%2Ftime-to-buy.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}], "overall_sentiment_score": 0.259883, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.659686", "ticker_sentiment_score": "0.384555", "ticker_sentiment_label": "Bullish"}]}, {"title": "Company News for May 2, 2024", "url": "https://www.zacks.com/stock/news/2266595/company-news-for-may-2-2024", "time_published": "20240502T085900", "authors": ["Zacks Equity Research"], "summary": "Companies In The News Are: CVS, PFE, PPL, ADP.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.990678"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.199677, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADP", "relevance_score": "0.588876", "ticker_sentiment_score": "0.398677", "ticker_sentiment_label": "Bullish"}, {"ticker": "CVS", "relevance_score": "0.588876", "ticker_sentiment_score": "-0.125202", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.588876", "ticker_sentiment_score": "0.437657", "ticker_sentiment_label": "Bullish"}]}, {"title": "Viagra trademark exclusive property of Pfizer, rules Delhi High Court", "url": "https://www.business-standard.com/industry/news/viagra-trademark-exclusive-property-of-pfizer-rules-delhi-high-court-124050200464_1.html", "time_published": "20240502T073016", "authors": ["Vasudha Mukherjee"], "summary": "The Delhi High Court has affirmed that the American pharmaceutical giant Pfizer exclusively owns the trademark 'Viagra', a medication widely used to treat erectile dysfunction.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2024-05/02/full/1714634141-6022.jpg?im=FeatureCrop,size=(826,465)", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.034061, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.541149", "ticker_sentiment_score": "-0.158146", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Investor Optimism Improves Slightly Following Fed Decision - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ", "url": "https://www.benzinga.com/news/24/05/38573272/investor-optimism-improves-slightly-following-fed-decision", "time_published": "20240502T063750", "authors": ["Avi Kapoor"], "summary": "The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the \"Fear\" zone on Wednesday. U.S. stocks settled mixed on Wednesday, after the Federal Reserve announced its policy decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": -0.058634, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WBD", "relevance_score": "0.099066", "ticker_sentiment_score": "-0.172892", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.19661", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "K", "relevance_score": "0.19661", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.19661", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.19661", "ticker_sentiment_score": "0.426656", "ticker_sentiment_label": "Bullish"}, {"ticker": "LEG", "relevance_score": "0.19661", "ticker_sentiment_score": "0.426656", "ticker_sentiment_label": "Bullish"}]}, {"title": "LACROIX announces the final sale of the Road Signs segment.", "url": "https://www.globenewswire.com/news-release/2024/05/02/2873811/0/en/LACROIX-announces-the-final-sale-of-the-Road-Signs-segment.html", "time_published": "20240502T053000", "authors": ["Lacroix Group"], "summary": "LACROIX announces the final saleof the Road Signs segment ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/747d101b-0f51-4180-bc32-7534fb5a017c", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.339706, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JCI", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOC", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXLSF", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLOUF", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "VC", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.065866", "ticker_sentiment_score": "0.029026", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer  ( PFE )  Q1 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/05/01/pfizer-pfe-q1-2024-earnings-call-transcript/", "time_published": "20240501T223016", "authors": ["Motley Fool Transcribing"], "summary": "PFE earnings call for the period ending March 31, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.286028, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.003432", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHVN", "relevance_score": "0.003432", "ticker_sentiment_score": "-0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.003432", "ticker_sentiment_score": "0.112968", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.003432", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.003432", "ticker_sentiment_score": "0.112968", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.003432", "ticker_sentiment_score": "0.106181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.003432", "ticker_sentiment_score": "0.066308", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZQ", "relevance_score": "0.003432", "ticker_sentiment_score": "0.053439", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLN", "relevance_score": "0.003432", "ticker_sentiment_score": "0.03732", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.003432", "ticker_sentiment_score": "0.112968", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.06171", "ticker_sentiment_score": "0.170231", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Pfizer Stock Blasted More Than 6% Higher Today", "url": "https://www.fool.com/investing/2024/05/01/why-pfizer-stock-blasted-more-than-6-higher-today/", "time_published": "20240501T215553", "authors": ["Eric Volkman"], "summary": "A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.", "banner_image": "https://g.foolcdn.com/editorial/images/775390/medical-professional-holding-dollar-sign-paperweight.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998947"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.280797, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.512596", "ticker_sentiment_score": "0.353119", "ticker_sentiment_label": "Bullish"}]}, {"title": "Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38561882/dow-jumps-200-points-following-fed-decision-pfizer-earnings-top-estimates", "time_published": "20240501T183212", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%, as widely expected. The Dow traded up 0.55% to 38,022.21 while the NASDAQ rose 0.19% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Pfizer-shutterstock2_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.02903, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.068502", "ticker_sentiment_score": "-0.143562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.074447", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.021569", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.068502", "ticker_sentiment_score": "-0.143562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.125211", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKY", "relevance_score": "0.136499", "ticker_sentiment_score": "0.449611", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPGI", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.024627", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.379389", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.2035", "ticker_sentiment_score": "-0.066229", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEG", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.085301", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday? - Albemarle  ( NYSE:ALB ) ", "url": "https://www.benzinga.com/markets/equities/24/05/38559813/us-stocks-mixed-ahead-of-fed-meeting-chipmakers-tumble-after-amd-earnings-bitcoin-sinks-whats-dr", "time_published": "20240501T170702", "authors": ["Piero Cingari"], "summary": "Traders are treading cautiously in Wednesday's session, seeking more clarity on the Federal Reserve's stance with inflation reports exceeding expectations.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/bulls-and-bears.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.050881, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALL", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRO", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.067727", "ticker_sentiment_score": "0.056307", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYCB", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.134968", "ticker_sentiment_score": "0.1405", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLIC", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.134968", "ticker_sentiment_score": "0.1405", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZH", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVN", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.134968", "ticker_sentiment_score": "-0.412536", "ticker_sentiment_label": "Bearish"}]}, {"title": "Pfizer  ( PFE )  Q1 Earnings & Sales Top, EPS Guidance Raised", "url": "https://www.zacks.com/stock/news/2266222/pfizer-pfe-q1-earnings-sales-top-eps-guidance-raised", "time_published": "20240501T154300", "authors": ["Zacks Equity Research"], "summary": "Pfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.093123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BHVN", "relevance_score": "0.027319", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIP", "relevance_score": "0.135959", "ticker_sentiment_score": "0.209635", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LGND", "relevance_score": "0.162802", "ticker_sentiment_score": "0.200931", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.318897", "ticker_sentiment_score": "0.212276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNTX", "relevance_score": "0.08183", "ticker_sentiment_score": "-0.110845", "ticker_sentiment_label": "Neutral"}]}, {"title": "Amazon-backed Anthropic launches iPhone app and business tier to compete with OpenAI's ChatGPT", "url": "https://www.cnbc.com/2024/05/01/anthropic-iphone-ai-app-business-plan-to-compete-with-openai-announced.html", "time_published": "20240501T150001", "authors": ["Hayden Field"], "summary": "Anthropic on Wednesday announced its first-ever enterprise offering, as well as its first iOS app.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107320283-1697736965856-gettyimages-1734163998-omarques_19102023_TECHPOL-1.jpeg?v=1714573631&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.094987, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ASAN", "relevance_score": "0.07913", "ticker_sentiment_score": "0.001028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.039614", "ticker_sentiment_score": "0.124395", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.010255", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.039614", "ticker_sentiment_score": "0.112583", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.039614", "ticker_sentiment_score": "0.112583", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.039614", "ticker_sentiment_score": "0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.039614", "ticker_sentiment_score": "-0.12144", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going With Pfizer Stock On Wednesday? - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38554240/pfizer-embraces-direct-to-consumer-model-for-covid-antiviral-says-comirnaty-revenues-continue-to-", "time_published": "20240501T143835", "authors": ["Vandana Singh"], "summary": "On Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign exchange of $107 million, or 1%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.04049, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.254751", "ticker_sentiment_score": "0.013458", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.551622", "ticker_sentiment_score": "0.149321", "ticker_sentiment_label": "Neutral"}]}, {"title": "Remembering Joe Rosenberg, a Wall Street Veteran and Man of All Markets", "url": "https://www.barrons.com/amp/articles/joe-rosenberg-dies-loews-strategist-9d033987", "time_published": "20240501T142300", "authors": ["Andrew Bary"], "summary": "Joe Rosenberg, a keen observer of financial markets and the longtime chief investment officer at Loews, died Monday at 91. Rosenberg, who was born in Eschwege, Germany, and emigrated to the U.S. in 1939, spent more than 50 years on Wall Street, most of them at Loews, the conglomerate controlled ...", "banner_image": "https://images.barrons.com/im-60433391/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.13795, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.101797", "ticker_sentiment_score": "0.09155", "ticker_sentiment_label": "Neutral"}, {"ticker": "L", "relevance_score": "0.29887", "ticker_sentiment_score": "0.076372", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.101797", "ticker_sentiment_score": "0.066301", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.051003", "ticker_sentiment_score": "0.186416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNA", "relevance_score": "0.051003", "ticker_sentiment_score": "-0.151379", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK  ( NYSE:GSK ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38551919/gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook", "time_published": "20240501T134217", "authors": ["Vandana Singh"], "summary": "Wednesday, GSK Plc GSK reported first-quarter sales of $9.33 billion ( 7.4 billion Sterling Pounds ) , up 10% Y/Y and 13% excluding COVID. Vaccines' sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/GlaxoSmithKline-building--London--2-Febr.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.303845, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GSK", "relevance_score": "0.551622", "ticker_sentiment_score": "0.278662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.171485", "ticker_sentiment_score": "-0.301977", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.171485", "ticker_sentiment_score": "-0.301977", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:GBP", "relevance_score": "0.086245", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Jumps On Hiked Guidance, Big Earnings Beat", "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q1-2024/", "time_published": "20240501T125000", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Pfizer Stock Jumps After Pharma Giant Raises Outlook On Big Quarterly Beat Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/08/stock-Pfizer-03-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.307318, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.929758", "ticker_sentiment_score": "0.506323", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pfizer  ( PFE )  Q1 Earnings and Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2265664/pfizer-pfe-q1-earnings-and-revenues-beat-estimates", "time_published": "20240501T115505", "authors": ["Zacks Equity Research"], "summary": "Pfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.137221, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.404563", "ticker_sentiment_score": "0.146695", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.209365", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales", "url": "https://www.cnbc.com/2024/05/01/pfizer-pfe-earnings-q1-2024.html", "time_published": "20240501T111354", "authors": ["Annika Kim Constantino"], "summary": "The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107341902-1701439925715-gettyimages-1232570628-porzycki-pfizerph210427_npgJv.jpeg?v=1714497742&w=1920&h=1080", "source": "CNBC", "category_within_source": "Earnings", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999491"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.096946, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.697241", "ticker_sentiment_score": "-0.007776", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer's 44% Decline In Profits Still Tops Estimates-Stock Bounces From Decade Low", "url": "https://www.forbes.com/sites/dereksaul/2024/05/01/pfizers-44-decline-in-profits-still-tops-estimates-stock-bounces-from-decade-low/", "time_published": "20240501T110256", "authors": ["Derek Saul"], "summary": "Pfizer Earnings Beats Estimates As Stock Bounces From Decade Low Forbes ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6631551872290f2cebe0a12a/0x0.jpg?format=jpg&crop=4769,2684,x0,y212,safe&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.170584, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.169081", "ticker_sentiment_score": "0.012948", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.330654", "ticker_sentiment_score": "0.110102", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq, S&P 500 Futures Signal Weaker Open As Fed Decision Looms: What's Going On With Markets? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38544746/wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-reli", "time_published": "20240501T104410", "authors": ["Shanthi Rexaline"], "summary": "A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.'s AMD underwhelming quarterly report, exerting pressure on the tech sector and the broader market.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Nasdaq.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.996023"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.012028, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALL", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.037397", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLIC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIZF", "relevance_score": "0.036926", "ticker_sentiment_score": "-0.02999", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.014478", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLCO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.202132", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Stock market today: futures drop after Starbucks and McDonald's misses", "url": "https://markets.businessinsider.com/news/stocks/stock-market-news-futures-trading-amazon-earnings-starbucks-mcdonalds-fed-2024-5", "time_published": "20240501T090300", "authors": ["Theron Mohamed"], "summary": "Stock Market News: Futures Drop After Starbucks and McDonald's Misses - Markets Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.988787"}], "overall_sentiment_score": 0.012192, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.070517", "ticker_sentiment_score": "-0.236781", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MA", "relevance_score": "0.070517", "ticker_sentiment_score": "0.177121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDNDF", "relevance_score": "0.209365", "ticker_sentiment_score": "0.054905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.209365", "ticker_sentiment_score": "0.127137", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.070517", "ticker_sentiment_score": "0.177121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWQGF", "relevance_score": "0.070517", "ticker_sentiment_score": "0.038577", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investor Sentiment Falls, Dow Snaps Five-Month Win Streak - Mastercard  ( NYSE:MA ) , Coca-Cola  ( NYSE:KO ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38542052/investor-sentiment-falls-dow-snaps-five-month-win-streak", "time_published": "20240501T074227", "authors": ["Avi Kapoor"], "summary": "The CNN Money Fear and Greed index showed a decline in the overall market sentiment, but the index remained in the \"Fear\" zone on Tuesday. U.S. stocks settled lower on Tuesday, with the Dow Jones index dipping more than 550 points during the session.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Businessman-touching-stock-market-graph-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.183315, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "YUM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}, {"ticker": "MA", "relevance_score": "0.105141", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.105141", "ticker_sentiment_score": "0.310726", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QCOM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.105141", "ticker_sentiment_score": "-0.316184", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MMM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCD", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}]}, {"title": "Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday - Amazon.com  ( NASDAQ:AMZN ) , Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38542047/amazon-pfizer-and-3-stocks-to-watch-heading-into-wednesday", "time_published": "20240501T074209", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Pfizer Inc. PFE to report quarterly earnings at 54 cents per share on revenue of $14.20 billion before the opening bell, according to data ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Amazon-logo.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.997335"}], "overall_sentiment_score": 0.184964, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "YUM", "relevance_score": "0.388879", "ticker_sentiment_score": "0.09516", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.265378", "ticker_sentiment_score": "0.260958", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.178314", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.388879", "ticker_sentiment_score": "0.389426", "ticker_sentiment_label": "Bullish"}, {"ticker": "LEG", "relevance_score": "0.388879", "ticker_sentiment_score": "-0.093455", "ticker_sentiment_label": "Neutral"}]}, {"title": "Amazon.com  ( AMZN )  Q1 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/04/30/amazoncom-amzn-q1-2024-earnings-call-transcript/", "time_published": "20240501T021511", "authors": ["Motley Fool Transcribing"], "summary": "AMZN earnings call for the period ending March 31, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.295784, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.009838", "ticker_sentiment_score": "0.062677", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.004919", "ticker_sentiment_score": "0.088984", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.004919", "ticker_sentiment_score": "0.094014", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.004919", "ticker_sentiment_score": "0.112706", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.004919", "ticker_sentiment_score": "0.131778", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUBF", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.004919", "ticker_sentiment_score": "0.094014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDDY", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCOV", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYAOF", "relevance_score": "0.004919", "ticker_sentiment_score": "0.131778", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.088363", "ticker_sentiment_score": "0.134294", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWG", "relevance_score": "0.004919", "ticker_sentiment_score": "0.143244", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.004919", "ticker_sentiment_score": "0.069439", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Medical Dynamometers Market to Witness Upsurge in Growth at a CAGR of ~6% by 2030 | DelveInsight", "url": "https://www.prnewswire.com/news-releases/global-medical-dynamometers-market-to-witness-upsurge-in-growth-at-a-cagr-of-6-by-2030--delveinsight-302131049.html", "time_published": "20240430T213100", "authors": ["DelveInsight Business Research", "LLP"], "summary": "The medical dynamometers market is predicted to surge owing to the rise in bone-related conditions like osteoporosis and arthritis, along with an uptick in sports injuries and the expanding elderly demographic.", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.359048, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "AHKSF", "relevance_score": "0.048671", "ticker_sentiment_score": "0.049387", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYYNF", "relevance_score": "0.048671", "ticker_sentiment_score": "0.049387", "ticker_sentiment_label": "Neutral"}, {"ticker": "STMM", "relevance_score": "0.048671", "ticker_sentiment_score": "0.049387", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.048671", "ticker_sentiment_score": "0.052484", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.024347", "ticker_sentiment_score": "0.222563", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.024347", "ticker_sentiment_score": "0.012467", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBIGF", "relevance_score": "0.048671", "ticker_sentiment_score": "0.052484", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.024347", "ticker_sentiment_score": "0.012467", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.024347", "ticker_sentiment_score": "0.314925", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EPRX", "relevance_score": "0.048671", "ticker_sentiment_score": "0.013843", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.07295", "ticker_sentiment_score": "0.033218", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSBHF", "relevance_score": "0.024347", "ticker_sentiment_score": "0.012467", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.048671", "ticker_sentiment_score": "0.049387", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEVA", "relevance_score": "0.024347", "ticker_sentiment_score": "0.012467", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.097161", "ticker_sentiment_score": "0.054812", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLPG", "relevance_score": "0.048671", "ticker_sentiment_score": "0.052484", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASBRF", "relevance_score": "0.048671", "ticker_sentiment_score": "0.049387", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATBPF", "relevance_score": "0.024347", "ticker_sentiment_score": "0.012467", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.07295", "ticker_sentiment_score": "0.033218", "ticker_sentiment_label": "Neutral"}]}, {"title": "BioNTech  ( BNTX )  to Report Q1 Earnings: Is a Beat in Store?", "url": "https://www.zacks.com/stock/news/2265282/biontech-bntx-to-report-q1-earnings-is-a-beat-in-store", "time_published": "20240430T155800", "authors": ["Zacks Equity Research"], "summary": "On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/2216.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999985"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.071326, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATRA", "relevance_score": "0.282234", "ticker_sentiment_score": "0.030022", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.171688", "ticker_sentiment_score": "0.167546", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.227538", "ticker_sentiment_score": "0.094039", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.614315", "ticker_sentiment_score": "0.061227", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa\u2122 in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/04/30/2872564/0/en/Biodexa-s-Licensor-Emtora-to-Announce-Phase-2-Clinical-Trial-Results-of-eRapa-in-Familial-Adenomatous-Polyposis-to-be-Presented-at-Prestigious-2024-Digestive-Disease-Week-Annual-Me.html", "time_published": "20240430T155200", "authors": ["Biodexa Pharmaceuticals PLC"], "summary": "April ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/8367259c-e117-4264-9988-26f7e36b032f", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.07909, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.03878", "ticker_sentiment_score": "0.078894", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDRX", "relevance_score": "0.154207", "ticker_sentiment_score": "0.001348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?", "url": "https://www.zacks.com/stock/news/2265330/will-these-5-drugbiotech-stocks-beat-q1-earnings-forecast", "time_published": "20240430T152000", "authors": ["Zacks Equity Research"], "summary": "Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.158563, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.042953", "ticker_sentiment_score": "0.043835", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.253426", "ticker_sentiment_score": "0.062112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.042953", "ticker_sentiment_score": "0.043835", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.293841", "ticker_sentiment_score": "0.13754", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.212301", "ticker_sentiment_score": "0.129453", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.293841", "ticker_sentiment_score": "0.163676", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.333444", "ticker_sentiment_score": "0.138141", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38524922/pfizer-sees-less-revenue-from-covid-19-treatments-stock-faces-headwinds-ahead-of-q1", "time_published": "20240430T151850", "authors": ["Surbhi Jain"], "summary": "Pfizer Inc PFE stock has declined significantly due to decreased revenue from its COVID-19 products. The stock is down 34.61% over the past year, and 10.94% year-to-date. While Pfizer's dividend appears to be inexpensive, investors are noting significant risks facing the company ahead of ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/30/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.723405"}], "overall_sentiment_score": 0.036084, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.701177", "ticker_sentiment_score": "0.256556", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( PFE )  - Analyzing Pfizer's Short Interest - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/insights/short-sellers/24/04/38523290/pfe-analyzing-pfizers-short-interest", "time_published": "20240430T144521", "authors": ["Benzinga Insights"], "summary": "Pfizer's PFE short percent of float has fallen 9.45% since its last report. The company recently reported that it has 65.00 million shares sold short, which is 1.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.264538, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.212115", "ticker_sentiment_score": "0.081887", "ticker_sentiment_label": "Neutral"}]}, {"title": "Eli Lilly  ( LLY )  Tops Q1 Earnings Estimates", "url": "https://www.zacks.com/stock/news/2264689/eli-lilly-lly-tops-q1-earnings-estimates", "time_published": "20240430T115505", "authors": ["Zacks Equity Research"], "summary": "Lilly (LLY) delivered earnings and revenue surprises of 1.98% and 0.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.155276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.40348", "ticker_sentiment_score": "0.181105", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.140076", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's in the Cards for First Solar  ( FSLR )  in Q1 Earnings?", "url": "https://www.zacks.com/stock/news/2264764/whats-in-the-cards-for-first-solar-fslr-in-q1-earnings", "time_published": "20240430T115000", "authors": ["Zacks Equity Research"], "summary": "First Solar's (FSLR) Q1 results are likely to reflect the benefits of increased sales volume and average selling price per watt sold.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.188767, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FSLR", "relevance_score": "0.391486", "ticker_sentiment_score": "0.281344", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RUN", "relevance_score": "0.116348", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.116348", "ticker_sentiment_score": "0.086248", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSIQ", "relevance_score": "0.116348", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXT(EXP20091224)", "relevance_score": "0.05833", "ticker_sentiment_score": "0.067975", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NXT", "relevance_score": "0.116348", "ticker_sentiment_score": "0.138853", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Top Stocks to Buy in May", "url": "https://www.fool.com/investing/2024/04/30/5-top-stocks-to-buy-in-may/", "time_published": "20240430T114500", "authors": ["and Neha Chamaria", "Keith Speights", "Demitri Kalogeropoulos", "Daniel Foelber", "Anders Bylund"], "summary": "Whether you're looking for a proven player, passive income, or a breakout growth story, there are plenty of stocks worth buying this spring.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774654%2Fgettyimages-1032524356-1201x691-f260cd6-1.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999976"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.236543, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.225321", "ticker_sentiment_score": "0.213748", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NFLX", "relevance_score": "0.022837", "ticker_sentiment_score": "0.079317", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.225321", "ticker_sentiment_score": "0.054189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.022837", "ticker_sentiment_score": "0.079317", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.158818", "ticker_sentiment_score": "0.08883", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.20331", "ticker_sentiment_score": "0.13621", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEE", "relevance_score": "0.181137", "ticker_sentiment_score": "0.188922", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation", "url": "https://www.fool.com/investing/2024/04/30/1-unstoppable-dividend-growth-stock-to-buy-right/", "time_published": "20240430T110000", "authors": ["Josh Kohn-Lindquist"], "summary": "The temporary problems facing Zoetis could create an incredible opportunity for investors thinking decades ahead.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773731%2Fgetty-happy-interested-cat-and-dog.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.146802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZTS", "relevance_score": "0.871815", "ticker_sentiment_score": "0.241117", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.048523", "ticker_sentiment_score": "-0.007952", "ticker_sentiment_label": "Neutral"}]}, {"title": "Council Post: From Stigma To Support: Empowering Progress Despite Barriers In Breast Cancer", "url": "https://www.forbes.com/sites/forbesnonprofitcouncil/2024/04/30/from-stigma-to-support-empowering-progress-despite-barriers-in-breast-cancer/", "time_published": "20240430T110000", "authors": ["Paula Schneider"], "summary": "From Stigma To Support: Empowering Progress Despite Barriers In Breast Cancer Forbes ...", "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-4170_400_549922d942cda9fc4a4df59762a59086.jpg", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.088926, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.035929", "ticker_sentiment_score": "0.107362", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist", "url": "https://www.fool.com/investing/2024/04/30/buying-beaten-down-high-yield-dividend-stock/", "time_published": "20240430T095000", "authors": ["Keith Speights"], "summary": "The sun could be peeking through the dark clouds for Pfizer.", "banner_image": "https://g.foolcdn.com/editorial/images/774882/scientists-looking-at-screen-with-icons.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995973"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.072607, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BHVN", "relevance_score": "0.063091", "ticker_sentiment_score": "0.042048", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.616089", "ticker_sentiment_score": "0.121425", "ticker_sentiment_label": "Neutral"}]}, {"title": "Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead", "url": "https://www.fool.com/investing/2024/04/30/forget-nvidia-billionaires-sell-buy-dividend-stock/", "time_published": "20240430T090600", "authors": ["Sean Williams"], "summary": "Wall Street's brightest, most successful billionaire money managers are ditching Nvidia in favor of two time-tested income stocks with yields of 6.6%!", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774824%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.992549"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.228602, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AMD", "relevance_score": "0.029043", "ticker_sentiment_score": "0.099927", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.337811", "ticker_sentiment_score": "0.257979", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "T", "relevance_score": "0.201164", "ticker_sentiment_score": "0.081382", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.229149", "ticker_sentiment_score": "0.251834", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "MicroStrategy  ( MSTR )  Q1 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/04/29/microstrategy-mstr-q1-2024-earnings-call-transcrip/", "time_published": "20240430T013016", "authors": ["Motley Fool Transcribing"], "summary": "MSTR earnings call for the period ending March 31, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.838487"}, {"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.250011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.010784", "ticker_sentiment_score": "0.142069", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.150089", "ticker_sentiment_score": "0.160685", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.016176", "ticker_sentiment_score": "0.108467", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSCO", "relevance_score": "0.005392", "ticker_sentiment_score": "0.09122", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.005392", "ticker_sentiment_score": "0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.005392", "ticker_sentiment_score": "0.09122", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNXYF", "relevance_score": "0.005392", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.692509", "ticker_sentiment_score": "0.435991", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTG", "relevance_score": "0.005392", "ticker_sentiment_score": "0.024172", "ticker_sentiment_label": "Neutral"}]}]}